Absorption, Metabolism, and Excretion of NS-580 in Healthy Males

Phase 1, open-label, single-arm trial of friluglanstat in endometriosis and chronic pelvic pain syndrome (CPPS), sponsored by Nippon Shinyaku. Primary endpoints: Area under the concentration-time curve from time 0 to infinity at 28 days, Area under the concentration-time curve from time 0 to infinity for Total Radioactivity at 56 days and 12 more. Started Nov 2023; status: completed.